In people with atrial fibrillation unsuitable for warfarin, apixaban reduces the risk of stroke compared with aspirin, with no difference in major bleeding
Evid Based Med
.
2011 Dec;16(6):187-8.
doi: 10.1136/ebm.2011.0023.
Epub 2011 Jul 29.
Authors
Renato D Lopes
1
,
David A Garcia
Affiliation
1
Cardiology, Duke University Medical Center, Duke Clinical Research Institute, Durham, North Carolina 27705, USA. renato.lopes@duke.edu
PMID:
21803760
DOI:
10.1136/ebm.2011.0023
No abstract available
Publication types
Comment